Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Cipla Bommasandra facility gets VAI classification from USFDA

Cipla gets exclusive rights to market ophthalmic drug across 11 countries

Ruchika Sharma20 March 2025 1:30 PM IST

APP13007 is a novel, patent protected and USFDA approved ophthalmic product.

Bajaj Healthcare gets CDSCO panel nod for Phase III trials for Cenobamate Tablets

Bajaj Healthcare gets CDSCO panel nod for Phase III trials for anti-seizure drug

Ruchika Sharma20 March 2025 12:30 PM IST

"With this, Bajaj Healthcare aims to provide a safe and effective treatment option for epilepsy patients in India," the Company stated.

Sanofi to buy Autoimmune Disease treatment from Dren Bio for up to USD 1.9 billion

Ruchika Sharma20 March 2025 11:30 AM IST

Paris: Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi...

Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian markets

Ruchika Sharma20 March 2025 10:30 AM IST

Mumbai: Marksans Pharma Limited has announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna,...

Pfizer discontinues development of danuglipron for chronic weight management

Pfizer to exit Haleon

Ruchika Sharma19 March 2025 6:30 PM IST

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group.As part of the...

Raid in Paschim Vihar: Counterfeit medicine racket busted

Patients benefit Rs 3,788 crore annually from NLEM 2022 price revision

Ruchika Sharma19 March 2025 5:30 PM IST

New Delhi: Average price reduction due to fixation or refixation of prices under National List of Essential Medicines, 2022 resulted in estimated...

Alembic buys UTI-focused Utility Therapeutics in USD 12 million deal

Sun Pharma subsidiary acquires Antibe Therapeutics for Rs 27 crores

Ruchika Sharma19 March 2025 4:30 PM IST

Mumbai: In a recent BSE filing, Sun Pharmaceutical Industries Limited has informed that TARO Pharmaceuticals Inc., a subsidiary of Sun...

Granules India Hyderabad API facility gets 1 USFDA observation

Granules Europe dissolves

Ruchika Sharma19 March 2025 3:30 PM IST

Granules Europe Limited, a wholly owned foreign subsidiary of Granules India situated at Bath, United Kingdom has been voluntarily dissolved with...

Marksans Pharma gets USFDA nod for heartburn drug

Marksans Pharma arm gets marketing authorization for muscle relaxant tablets in UK

Ruchika Sharma19 March 2025 2:30 PM IST

Mumbai: Marksans Pharma Limited's wholly owned subsidiary in the UK, Relonchem Limited receives marketing authorization for the product Baclofen...

JnJ seeks USFDA approval for Tremfya label update

JnJ Nipocalimab gets USFDA Fast Track designation for Sjogren's disease

Ruchika Sharma19 March 2025 1:30 PM IST

Spring House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for...

LIC eyes entry into health insurance space by month end

Ruchika Sharma19 March 2025 12:30 PM IST

The Life Insurance Corporation of India (LIC) is expected to make a decision to buy a stake in a health insurance company by the March end, according...

Zydus Lifesciences bags USFDA nod for prostate cancer drug Apalutamide

Ruchika Sharma19 March 2025 11:30 AM IST

Ahmedabad: Pharma major, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok